Golimumab improves insulin production and blood sugar control in T1D: NEJM
Golimumab Overview - Creative Biolabs
Golimumab preserves beta-cell function in children and young adults wit
Type 1 Diabetes Research Advances
IJMS | Free Full-Text | Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases
Golimumab preserves beta-cell function in children and young adults with Type 1 diabetes
Fighting the uphill battle to cure type 1 diabetes - Lee - 2021 - Journal of Diabetes Investigation - Wiley Online Library
VisualAbstract: Golimumab effective at preserving insulin production in type 1 diabetes | 2 Minute Medicine
Neues in der Diabetestherapie | DGE Blog
Golimumab for Type 1 Diabetes - DSM
Golimumab May Reduce Insulin Use in Newly Diagnosed Type 1 Diabetes - Endocrinology Advisor
How Can Golimumab Help Kids With Newly Diagnosed Type 1 Diabetes?
Golimumab Use in Type 1 Diabetes
Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes | NEJM
JPM | Free Full-Text | Personalized Immunotherapies for Type 1 Diabetes: Who, What, When, and How?
How Does SIMPONI® (golimumab) Work
Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes | NEJM
Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes | NEJM
Antikörper bremst Typ-1-Diabetes
Medlet som bromsar processen mot typ 1-diabetes - Diabetes Wellness Sverige
Current and future therapies for type 1 diabetes | SpringerLink
Biomolecules | Free Full-Text | Beta Cell Therapies for Preventing Type 1 Diabetes: From Bench to Bedside
New Frontiers in the Treatment of Type 1 Diabetes - ScienceDirect
Patient Resources | SIMPONI® (golimumab)
TNF--Blocker rettet Betazellen | PZ – Pharmazeutische Zeitung
